© - UVic Genome BC Proteomics Centre

Results|UVic PeptideTracker

You searched for: VTEPISAESGEQVER

UniProtKB Accession Protein Gene Organism Peptide Sequence Concentration Range Concentration Range Peptide ID Special Residues Special Residues Molecular Weight GRAVY Score Transitions Transitions Retention Time Retention Time Percent Organic Solution Percent Organic Solution Gradients Gradinets AAA CZE
UniProtKB Accession Protein Gene Organism Peptide Sequence Concentration Range Concentration Range Peptide ID Special Residues Special Residues Molecular Weight GRAVY Score Transitions Transitions Retention Time Retention Time Percent Organic Solution Percent Organic Solution AAA CZE
O14791 Apolipoprotein L1 APOL1 Homo sapiens VTEPISAESGEQVER View 1.10E+02(fmol/µL plasma)|28.6(fmol/µL plasma)|277.64(fmol/µL plasma)|327|Human Plasma|DOC-based|Promega Trypsin|6490|101.86(fmol/µL plasma)|1701(fmol/µL plasma) PEP2013091208

R+10

R+10 1639.78 -0.77

Agilent6490

Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|547.6054|5|Positive|y3|10|5|3|413.2382|380|111277.0,Agilent6490|2|True|547.6054|9|Positive|y4|10|5|3|541.2968|380|13164.0,Agilent6490|3|True|547.6054|5|Positive|y7++|10|5|3|407.7001|380|11052.0,Agilent6490|4|True|547.6054|17|Positive|y6|10|5|3|727.3609|380|8893.0,Agilent6490|5|True|547.6054|13|Positive|b2|10|5|3|201.1234|380|8017.0,Agilent6490|1|False|544.27|5|Positive|y3|10|5|3|403.23|380|111277.0,Agilent6490|2|False|544.27|9|Positive|y4|10|5|3|531.29|380|13164.0,Agilent6490|3|False|544.27|5|Positive|y7++|10|5|3|402.7|380|11052.0,Agilent6490|4|False|544.27|17|Positive|y6|10|5|3|717.35|380|8893.0,Agilent6490|5|False|544.27|13|Positive|b2|10|5|3|201.1234|380|8017.0 12.11(min) 12.11(min);12.58(min);12.120(min) 11.57 11.57;13.11;11.57 View Gradient 4,column: Agilent Zorbax Eclipse Plus C18 RRHD 2.1 x 150mm 1.8um, Time [min] | B [%] | Flow [ml/min], 0.00|2.70|0.4, 1.50|6.30|0.4, 16.00|13.50|0.4, 18.00|13.80|0.4, 33.00|22.50|0.4, 38.00|40.50|0.4, 39.00|81.00|0.4, 42.90|81.00|0.4, 43.00|2.70|0.4;Gradient 1,column: Agilent Zorbax Eclipse Plus C18 RRHD 2.1 x 150mm 1.8um, Time [min] | B [%] | Flow [ml/min], 0.00|3.00|0.4, 1.50|7.00|0.4, 16.00|15.00|0.4, 18.00|15.30|0.4, 33.00|25.00|0.4, 38.00|45.00|0.4, 39.00|90.00|0.4, 42.90|90.00|0.4, 43.00|3.00|0.4;Gradient 2,column: Agilent Zorbax Eclipse Plus C18 RRHD 2.1 x 150mm 1.8um, Time [min] | B [%] | Flow [ml/min], 0|1.5|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.77|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|1.5|0.4 10.000000 97.20
O14791 Apolipoprotein L1 APOL1 Homo sapiens VTEPISAESGEQVER NA NA PEP2017022482

R+10

R+10 1639.78 -0.77

Agilent6490

Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|547.6054|5|Positive|y3|10|5|3|413.2382|380|111277.0,Agilent6490|2|True|547.6054|9|Positive|y4|10|5|3|541.2968|380|13164.0,Agilent6490|3|True|547.6054|5|Positive|y7++|10|5|3|407.7001|380|11052.0,Agilent6490|4|True|547.6054|17|Positive|y6|10|5|3|727.3609|380|8893.0,Agilent6490|5|True|547.6054|13|Positive|b2|10|5|3|201.1234|380|8017.0,Agilent6490|1|False|544.27|5|Positive|y3|10|5|3|403.23|380|111277.0,Agilent6490|2|False|544.27|9|Positive|y4|10|5|3|531.29|380|13164.0,Agilent6490|3|False|544.27|5|Positive|y7++|10|5|3|402.7|380|11052.0,Agilent6490|4|False|544.27|17|Positive|y6|10|5|3|717.35|380|8893.0,Agilent6490|5|False|544.27|13|Positive|b2|10|5|3|201.1234|380|8017.0 NA NA NA NA NA NA 7.100 91.72
O14791 Apolipoprotein L1 APOL1 Homo sapiens VTEPISAESGEQVER View 1.10E+02(fmol/µL plasma)|28.6(fmol/µL plasma)|277.64(fmol/µL plasma)|327|Human Plasma|DOC-based|Promega Trypsin|6490|101.86(fmol/µL plasma)|1701(fmol/µL plasma) PEP2013020503

R+10

R+10 1639.78 -0.77

Agilent6490

Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|547.6054|5|Positive|y3|10|5|3|413.2382|380|111277.0,Agilent6490|2|True|547.6054|9|Positive|y4|10|5|3|541.2968|380|13164.0,Agilent6490|3|True|547.6054|5|Positive|y7++|10|5|3|407.7001|380|11052.0,Agilent6490|4|True|547.6054|17|Positive|y6|10|5|3|727.3609|380|8893.0,Agilent6490|5|True|547.6054|13|Positive|b2|10|5|3|201.1234|380|8017.0,Agilent6490|1|False|544.27|5|Positive|y3|10|5|3|403.23|380|111277.0,Agilent6490|2|False|544.27|9|Positive|y4|10|5|3|531.29|380|13164.0,Agilent6490|3|False|544.27|5|Positive|y7++|10|5|3|402.7|380|11052.0,Agilent6490|4|False|544.27|17|Positive|y6|10|5|3|717.35|380|8893.0,Agilent6490|5|False|544.27|13|Positive|b2|10|5|3|201.1234|380|8017.0 NA NA NA NA NA NA 6.800000 98.70
O14791 Apolipoprotein L1 APOL1 Homo sapiens VTEPISAESGEQVER View 1.10E+02(fmol/µL plasma)|28.6(fmol/µL plasma)|277.64(fmol/µL plasma)|327|Human Plasma|DOC-based|Promega Trypsin|6490|101.86(fmol/µL plasma)|1701(fmol/µL plasma) PEP2015091439

R+10

R+10 1639.78 -0.77

Agilent6490

Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|820.9037|29|Positive|y12++|10|5|2|656.3244|380|1.0,Agilent6490|5|True|820.9037|25|Positive|y13++|10|5|2|720.8457|380|5.0,Agilent6490|4|True|820.9037|29|Positive|y7|10|5|2|814.3929|380|4.0,Agilent6490|2|True|820.9037|41|Positive|y8|10|5|2|943.4355|380|2.0,Agilent6490|3|True|820.9037|37|Positive|y9|10|5|2|1014.4726|380|3.0,Agilent6490|1|False|815.8996|29|Positive|y12++|10|5|2|651.3202|380|1.0,Agilent6490|5|False|815.8996|25|Positive|y13++|10|5|2|715.8415|380|5.0,Agilent6490|4|False|815.8996|29|Positive|y7|10|5|2|804.3846|380|4.0,Agilent6490|2|False|815.8996|41|Positive|y8|10|5|2|933.4272|380|2.0,Agilent6490|3|False|815.8996|37|Positive|y9|10|5|2|1004.4643|380|3.0 NA NA NA NA NA NA 14.400000 64.09
O14791 Apolipoprotein L1 APOL1 Homo sapiens VTEPISAESGEQVER View 1.10E+02(fmol/µL plasma)|28.6(fmol/µL plasma)|277.64(fmol/µL plasma)|327|Human Plasma|DOC-based|Promega Trypsin|6490|101.86(fmol/µL plasma)|1701(fmol/µL plasma) PEP2015021602

R+10

R+10 1639.78 -0.77

Agilent6490

Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|820.9037|29|Positive|y12++|10|5|2|656.3244|380|1.0,Agilent6490|5|True|820.9037|25|Positive|y13++|10|5|2|720.8457|380|5.0,Agilent6490|4|True|820.9037|29|Positive|y7|10|5|2|814.3929|380|4.0,Agilent6490|2|True|820.9037|41|Positive|y8|10|5|2|943.4355|380|2.0,Agilent6490|3|True|820.9037|37|Positive|y9|10|5|2|1014.4726|380|3.0,Agilent6490|1|False|815.8996|29|Positive|y12++|10|5|2|651.3202|380|1.0,Agilent6490|5|False|815.8996|25|Positive|y13++|10|5|2|715.8415|380|5.0,Agilent6490|4|False|815.8996|29|Positive|y7|10|5|2|804.3846|380|4.0,Agilent6490|2|False|815.8996|41|Positive|y8|10|5|2|933.4272|380|2.0,Agilent6490|3|False|815.8996|37|Positive|y9|10|5|2|1004.4643|380|3.0 NA NA NA NA NA NA NA 72.21